vs. Control group 1 Screened candidate | vs. Control group 2 Beneficiary within inclusion criteria | |||
---|---|---|---|---|
Diabetes-related complications (all) | 1.14 | (0.67–1.93) | 0.60* | (0.36–1.00) |
Ischemic heart disease | 1.38 | (0.48–3.93) | 1.67 | (0.56–5.02) |
Stroke | 0.43 | (0.05–3.67) | 0.21 | (0.03–1.59) |
Retinopathy requiring surgery | 1.25 | (0.53–2.97) | 0.65 | (0.27–1.59) |
Neuropathy | 2.71 | (0.82–8.92) | 1.49 | (0.51–4.37) |
End-stage renal disease requiring dialysis | 0.63 | (0.07–5.52) | 0.15 | (0.02–1.16) |
Intensive care use | 1.09 | (0.48–2.45) | 0.63 | (0.28–1.43) |
Emergency care use | 0.79 | (0.49–1.29) | 0.59* | (0.37–0.94) |
All-cause hospitalization | 0.90 | (0.69–1.18) | 0.82 | (0.63–1.06) |
Dependency in activities of daily living | 0.78 | (0.22–2.80) | 0.69 | (0.20–2.38) |
All-cause mortality | 1.50 | (0.51–4.41) | 0.72 | (0.27–1.90) |